Abstract
MicroRNA-29a (miR-29a) has been extensively studied in tumor biology and fibrotic diseases, but little is known about its functional roles in vascular smooth muscle cell (VSMC) differentiation from embryonic stem cells (ESCs). Using well-established VSMC differentiation models, we have observed that miR-29a induces VSMC differentiation from mouse ESCs by negatively regulating YY1, a transcription factor that inhibits muscle cell differentiation and muscle-specific gene expression. Moreover, gene expression levels of three VSMC specific transcriptional factors were up-regulated by miR-29a over-expression, but down-regulated by miR-29a inhibition or YY1 over-expression. Taken together, our data demonstrate that miR-29a and its target gene, YY1, play a regulatory role in VSMC differentiation from ESCs in vitro and in vivo.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
3' Untranslated Regions
-
Actins / genetics
-
Actins / metabolism
-
Animals
-
Antagomirs / metabolism
-
Cell Differentiation
-
Cell Line
-
Mice
-
MicroRNAs / antagonists & inhibitors
-
MicroRNAs / genetics
-
MicroRNAs / metabolism*
-
Microfilament Proteins / genetics
-
Microfilament Proteins / metabolism
-
Microscopy, Fluorescence
-
Mouse Embryonic Stem Cells / cytology
-
Muscle Proteins / genetics
-
Muscle Proteins / metabolism
-
Myocytes, Smooth Muscle / cytology
-
Myocytes, Smooth Muscle / metabolism*
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
-
YY1 Transcription Factor / antagonists & inhibitors
-
YY1 Transcription Factor / genetics
-
YY1 Transcription Factor / metabolism*
Substances
-
3' Untranslated Regions
-
Actins
-
Antagomirs
-
MIRN29 microRNA, mouse
-
MicroRNAs
-
Microfilament Proteins
-
Muscle Proteins
-
Transcription Factors
-
YY1 Transcription Factor
-
Yy1 protein, mouse
-
alpha-smooth muscle actin, mouse
-
transgelin